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S U M M A R Y 
The amoebae's cytotoxicity test and the amoebae's lysis test were used to show 
possible interactions between rheumatoid factor (RF) and Entamoeba histolytica. 
Amoebae's cytotoxic activity ( A C A ) was inhibited by affinity chromatography 
purified antiamoebae rabbit I gG (R IgG) . Enhanced inhibition could be 
demonstrated with R IgG plus R F . But the same marked inhibition of A C A could be 
seen when replacing R F by heat inactivated normal human serum as a control. 
About 50% amoebae's lysis occurred when amoebae were brought together 
with native normal human serum (NNHS) as a source of complement. Amoebae's 
lysis increased to 60% when incubated with N H S plus human antiamoebae 
antibodies. No further augmentation could be obtained by the addition of R F . 
Using RIgG instead of human antibodies the lysis rate did not increase. Incubation 
of amoebae, N N H S , R IgG and R F even reduced amoebae's lysis. R F neither has an 
effect on A C A nor on complement mediated A L in vitro. 
K E Y W O R D S : Entamoeba histolytica; Amoebae's lysis; Rheumatoid factor. 
I N T R O D U C T I O N 
Rheumatoid factors (RF) are mostly IgM 
antibodies directed to various antigenic 
determinants of the Fc part of autologous or 
homologous IgG. The occurrence of IgM with 
R F like activity has not only been reported in 
collagen vascular diseases like rheumatoid 
arthritis, but also in numerous infectious 
diseases, like endocarditis 2 and parasitic 
infections like malaria, trypanosomiasis, 
leishmaniasis, schistosomiasis and oncho-
c e r c i a s i s 3 - 1 1 1 2 ' 1 6 - 1 7 " . The large number of 
infectious disease states known to be associated 
with rheumatoid factor production could be 
taken as evidence that this may be a normal 
immune response engendered in the host during 
many reversible and chronic infectious 
diseases9. 
C L A R K S O N & M E L L O W 4 reported on 
R F acting in a protective way by showing that 
R F protects uninfected rat pups and dams from 
Trypanosoma lewisii infections. G R E E N & 
P A C K E R 1 0 reported an inhibitory effect of R F 
on Plasmodium falciparum schizonts in vitro. 
To our knowledge no studies exist dealing 
with the interaction of amoebae and R F . 
In this work we investigated the in vitro 
interaction of E . histolytica with antiamoebae 
antibodies, human complement and 
rheumatoid factor. 
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M E T H O D S 
Amoebae: 
For all tests 72 hours cultured E . 
histolytica strain S F L 3 were taken. Modified 
TY-S-33 Medium was used6-7-8. Trophozoites 
were harvested and washed twice in RPM 1640 
medium plus 10% fetal calf serum ( R P M I / 
F C S ) . Then amoebae were adjusted to the 
wanted cell number per ml. 
Target cells: 
K 562, a human erythroleukemia cell line 
was used as target for amoebae's cytotoxicity. 
K 562 cells were cultured in R P M I / F C S . 
Rheumatoid Factor (RF) : 
The source of R F was serum from a patient 
with inactive rheumatoid arthritis. The titer of 
R F was 1:1280 as determined by agglutination 
of Latex particles coated with human IgG 
(Behring) and 1:20.000 as measured by 
haemagglutination of erythrocytes coated with 
rabbit IgG (Raha-Test, Fujirebio). The serum 
was used after heat inactivation and absorption 
of IgG by Protein A (Pansorbin, Behring) and 
centrifugation. The titer after absorption was 
1:5000 as measured by haemagglutination. 
Human serum: 
Freshly drawn normal human serum 
(NHS) was used which was negative with 
respect to all amoeba-specific serological tests 
( I IFT , I H A , E L I S A ) . The complement activity 
was 36 C H 5 ü U / m l . 
One part of the same serum was heat 
inactivated at 56°C for 30 minutes (HNHS) and 
treated in the same way as the RF-containing 
serum. 
Antibodies: 
For preparat ion of ant iamoebae 
antibodies, 30 ml of the serum from a patient 
suffering from an amoebic liver abscess was 
precipitated with a 33% ( N H 4 ) 2 S 0 4 solution, 
leaving the IgG-fraction in solution. The IgG 
fraction was dialysed against isotonic 
phosphate-buffered saline, pH-7.4. As shown 
by Immunoelectrophoresis, this preparation 
proved to be pure IgG (HIgG) and showed a 
highly positive reaction in the E L I S A 2 8 
For preparation of rabbit antiamoebae 
antibodies, we immunized rabbits 
intramuscularly with amoebic antigens. The 
immunization schedule was week 0, 1, 2, 6 and 
a boosting dose 3 months later. Blood was 
drawn by intracardial punction. 
For antigen preparation we took S F L 3 
amoebae and homogenized the cells with the 
Potter-Elvejlham homogenizer at O ü C . The 
resulting solution we mixed for the first 
immunizing dose with complete Freund's 
adjuvant, for the next doses with incomplete 
Freund's adjuvant. 
The rabbit sera were test by the E L I S A 
technique for antiamoebic activity21. Al l four 
sera showed positive reactions and were pooled. 
For getting pure IgG out of sera the 33% 
( N H 4 ) 2 S 0 4 precipitation method was used and 
proved by immunoelectrophoresis after dialysis 
against P B S . 
A F F I N I T Y C H R O M A T O G R A P H Y 
109 S F L 3 trophozoites were washed three 
times in PBS containing 2 mmol/ i phenyl-
methylsulfonylfluoride (PMSF) , 10 mmol/ i 
ethylendiaminotetraacetate ( E D T A ) and 10 
mmol / i E-aminocaproicacid ( E A C A ) and 
resuspended in this buffer at 4°C. Amoebae 
were homogenized by use of a Potter-Elvejlham 
homogenizer at 4 ° C . Subsequently, the 
homogenate was centrifuged at 1.500g for 20 
minutes at 4°C. Then the supernatant was 
subjected to centrifugation at 25.000g for one 
hour at 4°C. The pellet (membrane fraction) was 
resuspended in coupling buffer and coupled to 
CNBr activated Sepharose 4 B (Pharmacia Fine 
Chemicals, Vienna, Austria) according to the 
manufacturer's order i.a. 10 ml rabbit IgG (20 
mg/ml) were processed over the affinity 
column. After that the gel was washed by PBS 
until the base line at the UV monitoring system 
was reached. The amoebae specific antibodies 
were eluted with 0.1 mol/ i C H 3 C O O H , pH-
2.5. After elution, the antibody preparation 
( R I g G ) was immediately neutralised and 
dialysed against several changes of P B S . In the 
E L I S A we could show a 30 fold enrichment of 
antiamoebae antibodies in comparison with 
IgG before affinity cromatography. 
Amoebae's lysis test (AL ) 
Amoebae's lysis test was performed as 
described earlier 2 1 2 7. Amoebae were labelled 
with ? 1 Cr . Then 5 x 105 amoebae were mixed 
with human serum, R F , antibodies and R P M I / 
F C S and incubated at 37°C for 30 minutes. 
Each test was carried out six fold. 
Amoebae's cytotoxic activity test ( A C A ) 
A modified microcytotoxicity assay was 
performed as described for K and NK 
lymphocytes26. K 562 target cells were labelled 
with 5 iCr . The effector to target cell ratio was 
adjusted to 5:1. 100 JLÍ! amoebae (washed twice 
in R P M I / F C S in a concentration of 5 x lOVml) 
and 300 \A of R P M I / F C S or antibody or 
human serum or heat inactivated human serum 
or R F were mixed and incubated at 37°C for 30 
minutes. Then 200 \x\ K 562 (5 x lOVml in 
R P M I / F C S ) were added. Tubes were cen-
trifuged at 200g for 2 minutes and incubated at 
37°C for 10, 30 and 60 minutes. The assay was 
performed in triplicates. Target cell lysis was 
calculated from the radioactivity released into 
the supernatant. As a control K 562 were 
incubated with R P M I / F C S instead of amoebae 
(spontaneous lysis). 
R E S U L T S 
Amoebae's cytotoxic activity ( A C A ) 
against target cells was inhibited by 
antiamoebae antibodies. Figure 1 shows the 
Figure 1 
Inhibi t ion o f amoebae's cytotoxic activity by antibodies. 
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1 = S F L 3 amoebae + K562 
2 = S F L 3 amoebae + K562 + R I g G 
3 = S F L 3 amoebae + K562 + R I g G + R F 
4 = S F L 3 amoebae + K562 + R I g G + H N H S 
5 = K562 (spontaneous lysis) 
T A B L E 1 
Amoebae 's L y s i s ( A L ) w i th human serum,rheumato id factor and rabbit I g G after 30 ' incubat ion at 3 7 ° C 
(% lysis) 
E X P E R I M E N T S I I I I V 
Samples 
No . 
A m + R I g G + 
+ R F + N N H S 
A m + R I g G + 
+ R P M I + N N H S 
A m + R P M I + 
+ R P M I + N N H S 
A m + R P M I + 
+ R P M I + R P M I 
35.7 
36.8 
37.6 
37.5 
37.3 
37.4 
54.9 
51.1 
52.5 
51.1 
53.6 
51.8 
52.9 
50.6 
515 
51.9 
51.5 
51.7 
6.9 
6.7 
7.2 
6.9 
7.0 
6.8 
Mean 
Median 
Min-Max. 
37.1 
37.3 
35 .7 -37 .6 
52.5 
52.2 
51 .1 -54 .9 
51.7 
51.6 
50 .6 -52 .9 
A m (1 m l ) = 5 x 10 S F L 3 amoebae/ml . 
R F (1 ml ) = R F containing heat inact ivated human serum. 
R P M I (1 ml ) = R P M I 1640 + 10% F C S 
R I g G (1 ml) — Rabb i t I g G , ant iamoebae antibodies aff in i ty chromatographic pur i f ied, 100 m c g / m l . 
6.9 
6.9 
6.6-7.1 
N N H S (1 ml ) Native normal human serum. 
T A B L E 2 
Amoebae 's L y s i s ( A L ) w i th human serum, rheumatoid factor and human I g G after 3 0 ' incubat ion at 3 7 ° C 
(% lysis) 
E X P E R I M E N T S I I I I I I I V 
Samples A m + H I g G + A m + H i g G + A m + R P M I + A m + R P M I + 
No. + R F + N N H S + R P M I + N N H S + R P M I + N N H S + R P M I + R P M I 
1 61.2 61.2 54.2 6.6 
2 62.8 61.7 54.6 6.8 
3 61.4 61.3 55.6 7.1 
4 60.8 62.3 55.0 7.0 
5 61.1 62.1 54.6 6.7 
6 63.5 62.3 54.8 6.7 
Mean 61.8 61.8 54.8 6.8 
Median 61.3 61.9 54.7 6.8 
Min-Max. 60 .8 -63 .5 61 .2 -62 .3 54 .2 -55 .6 6 .7-7 .2 
A m ( l m l ) = 5 x 1 0 s S F L 3 amoebae/ml . 
R F (1 ml ) = R F containing heat inact ivated human serum. 
R P M I (1 ml) = R P M I 1640 + 10% F C S 
H I g G (1 ml) ~ H u m a n I g G fract ion f rom a serum f rom a patient suffering f rom an amoebic liver abscess, 1 m g / m l . 
N N H S (1 ml ) = Nat ive normal human serum. 
Table 1 shows complement mediated 
amoebae's lysis after incubation at 37°C for 30 
minutes. The addition of R IgG (25 ^g/ml final 
concentration) to N N H S did not increase the 
lysis rate compared to human serum alone. 
Surprisingly, incubation of amoebae, N N H S , 
R IgG plus R F gave a marked reduction of 
amoebae's lysis. Control experiments with R F 
alone revealed A L similar to the spontaneous 
amoebae's lysis. 
In the next set of experiments human anti­
bodies directed against amoebic antigens 
(HIgG) were used in the amoebae's lysis test 
together with N N H S as source of complement. 
Again N N H S alone lysed 55% of amoebae. 
N H S plus H IgG (0.25 mg/ml) produced about 
62% amoebae's lysis. No further increase in the 
rate of amoebae's lysis could be obtained by the 
addition of R F (Table 2). 
D I S C U S S I O N 
The capability of pathogenic strains of 
Entamoeba histolytica to lyse various cultured 
target cells has been described by several 
authors us ing d iverse exper imenta l 
approaches 1 1 3 1 8 ' 2 3- 2 5. Most probably structures 
of the amoebae's surface membrane are 
capacity of R I g G (130 Mg/ml final con­
centration) to inhibit the A C A against K 562 
target cells. This inhibition of A C A can be 
enhanced with R IgG plus R F . As a control we 
replaced R F containing serum by heat 
inactivated normal human serum. No 
difference between the two latter assays could 
be detected with regard to A C A . 
Complement in form of native normal 
human serum (NNHS) was able to inhibit the 
A.CA as well. After 60 minutes incubation K 
562 lysis was only 16%. The addition of R IgG 
led to an augmented inhibition of A C A (10% K 
562 lysis after 60 minutes) compared to N N H S 
alone. No further potentiating effect could be 
seen by the addition of R F (11% K 562 lysis), 
(data not shown in detail). 
Lysis tests: 
Amoebae's lysis test (AL ) already occurs 
when amoebae are brought together with N H S 
as a source of complement. About 50% of 
amoebae are lysed by the activation of 
complement. Amoebae's lysis increases to 60% 
when incubated with N N H S plus human 
antibodies to amoebae. 
involved in the cytotoxic action, presumably by 
mediating target and effector cell contact via a 
lectin like interaction19. Serum factors capable 
to inhibit the amoebae's cytotoxic activity are 
obviously interfering with the recognition of 
the target ce l l 1 3 1 4 . 
Antibodies directed against amoebic 
plasma membrane antigens inhibit the A C A . 
However, after binding to the membrane the 
antigen-antibody complexes are capped and 
partial ly shedded or internal ized. The 
reappearance of a smaller number of new 
surface antigens are thought to be responsible 
for A C A inhibition. A further amplification of 
these effects by R F was considered, because it 
has been reported that R F react with IgG which 
has undergone severe conformational change 
such as antigen binding'. In our assay no 
modulation of A C A by R F could be detected. 
These results can also be presumed for the 
situation in vivo. 
The slightly enhanced inhibition of A C A 
during incubation with R IgG plus H N H S could 
possibly be due to cytokines, such as interferon-
gamma or tumor necrosis factor, which are 
known to exert antiparasitic activity and occur 
in small amounts in N H S . 
Complement can lyse about 50% of 
amoebae after 30 or more minutes incubation 
at 37°C 1 S ' 2 ° . Beside this activation of the 
complement cascade via the alternative 
pathway, human antiamoebae antibodies also 
activate the classical pathway of complement24. 
A total amoebae's lysis rate of more than 60% 
after 30 minutes incubation at 37°C could be 
demonstrated in our assay. We expected R F to 
act as a second antibody and a complement 
magnet in form of a Clq binding site. In our 
hands R F did not show any influence on 
amoebae's lysis together with N N H S and 
H I g G . Forty per cent of amoebae are 
apparently resistant to complement lysis even 
under this maximally complement activated 
condition and prolonged incubation. 
In presence of R IgG we could not show an 
activation via the classical pathway of 
complement in the amoebae's lysis assay. By 
adding R F we found a reduction of amoebae's 
lysis. Those findings might be due by a missing 
activation of the classical pathway of the 
human complement system by these R I g G . 
However R IgG may react with R F . Amoebae 
antigen-RIgG-RF complexes on the amoebae's 
surface may lead to a transient immobilisation 
of the membrane followed by capping 
phenomena, partial ingestion and partial 
shedding of these immune complexes which in 
turn activate and consume complement far 
away from the amoebae's surface. 
Another possible mechanism for our 
findings is that these complexes on the 
amoebae's surface membrane may block C3b 
binding sites and hence inhibit assembling of 
C3 convertase of the alternative pathway of 
complement activation. So the complex C3BbP 
cannot be formed sufficiently on the amoebae's 
surface. 
In our study we could show that R F neither 
has an effect on amoebae's cytotoxic activity 
nor on complement mediated amoebae's lysis in 
vitro. Our results suggest that the interaction 
between antibodies against amoebic antigen 
and human IgG (RF) do not exert a protective 
role against extraintestinal amoebiasis. 
R E S U M O 
Interação do fator reumatóide e Entamoeba 
histolytica 
Testes para citotoxicidade e lise amebiana 
foram utilizados para demonstrar uma possível 
interação entre o fator reumatóide e a 
Entamoeba histolytica. A atividade citotóxica 
amebiana foi inibida pela IgG antiameba de 
coelho purificada através de cromatografia. 
Constatou-se inibição aumentada com IgG 
antiameba de coelho mais fator reumatóide. A 
mesma inibição acentuada da atividade 
citotóxica amebiana pôde ser constatada 
quando se substituiu o fator reumatóide por 
soro humano normal, inativado pelo calor, 
como controle. Cerca de 50% de lise amebiana 
ocorreu quando as amebas foram misturadas 
com soro normal humano como fonte de 
complemento. A lise amebiana aumentou para 
60% quando incubadas com soro humano 
normal, acrescido de anticorpos humanos 
antiameba. Nenhum aumento adicional pode 
ser obtido pela adição de fator reumatóide. 
Usando IgG antiameba de coelho em vez de 
anticorpos humanos, a proporção de lise não 
aumentou. A incubação de amebas com soro 
humano normal, IgG antiameba de coelho e 
fator reumatóide reduziu acentuadamente a lise 
amebiana. O fator reumatóide não teve efeito 
na atividade citotóxica amebiana, nem na lise 
amebiana mediada pelo complemento in vitro. 
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